After the National Institutes of Health (NIH) announced late Friday that it would be following a Trump administration ...

Analysts said the move comes amid rising trade tensions with the U.S. and as Illumina faces stiff competition in China’s ...

Element Biosciences’ bid to claim a slice of a DNA sequencing technology market dominated by Illumina has been helped by an impressive $277 million financing round backed by a wide range of ...

Gene sequencing machine maker Illumina forecast 2025 revenue largely below Wall Street estimates on Thursday, signaling ...

After China placed Illumina on a government watchlist this week, in response to new tariffs imposed by the Trump ...

The placement of Illumina in China's unreliable entity list could have disruptive implications. Read why I remain bullish on ...

Fintel reports that on February 10, 2025, Barclays downgraded their outlook for Illumina (NasdaqGS:ILMN) from Equal-Weight to ...

The Chinese government listed Illumina, whose global headquarters is in California, as an “unreliable entity” shortly after ...

Illumina's (ILMN) stock slid 5% post-market after it released its Q4 earnings report and reiterated its 2025 guidance, ...

For all of last year, Illumina’s net loss grew 5% from $1.161 billion to $1.223 billion, on revenue that fell 3% from $4.505 ...

Angle announces new results for dual analysis of CTC-DNA and ctDNA using Illumina assay and sequencing platform: London Saturday, February 1, 2025, 15:00 Hrs [IST] Angle plc, a wo ...

CTCs and ctDNA were then analysed using Illumina's customised 79 gene ... to introduce Parsortix-based CTC analysis for DNA dual analysis NGS sequencing, enabling analysis of large gene panels ...